1: Saklani P, Khan H, Singh TG, Gupta S, Grewal AK. Demethyleneberberine, a
potential therapeutic agent in neurodegenerative disorders: a proposed
mechanistic insight. Mol Biol Rep. 2022 Oct;49(10):10101-10113. doi:
10.1007/s11033-022-07594-9. Epub 2022 Jun 3. PMID: 35657450.
2: Li J, Zhang Q, Chen Y, Lu C, Tong Y. Pharmacokinetics, Tissue Distribution
and Excretion of Demethyleneberberine, a Metabolite of Berberine, in Rats and
Mice. Molecules. 2023 Nov 23;28(23):7725. doi: 10.3390/molecules28237725. PMID:
38067456; PMCID: PMC10708275.
3: Gupta S, Khan A, Vishwas S, Gulati M, Gurjeet Singh T, Dua K, Kumar Singh S,
Najda A, Sayed AA, Almeer R, Abdel-Daim MM. Demethyleneberberine: A possible
treatment for Huntington's disease. Med Hypotheses. 2021 Aug;153:110639. doi:
10.1016/j.mehy.2021.110639. Epub 2021 Jun 29. PMID: 34229236.
4: Zhao Y, Liu P, Luan H, Jiang H, Xu Y, Zhang Y, Zhang Y, Li R.
Demethyleneberberine alleviated the inflammatory response by targeting MD-2 to
inhibit the TLR4 signaling. Front Immunol. 2023 Apr 24;14:1130404. doi:
10.3389/fimmu.2023.1130404. PMID: 37168866; PMCID: PMC10165096.
5: Wang T, Yang XC, Ding Y, Zhang YJ, Ru YQ, Tan JJ, Xu F, Gao WW, Xia YM.
Cuprous oxide-demethyleneberberine nanospheres for single near-infrared light-
triggered photoresponsive-enhanced enzymatic synergistic antibacterial therapy.
J Mater Chem B. 2023 Feb 22;11(8):1760-1772. doi: 10.1039/d2tb02594a. PMID:
36723366.
6: Wang Z, Wang L, Shi B, Sun X, Xie Y, Yang H, Zi C, Wang X, Sheng J.
Demethyleneberberine promotes apoptosis and suppresses TGF-β/Smads induced EMT
in the colon cancer cells HCT-116. Cell Biochem Funct. 2021 Aug;39(6):763-770.
doi: 10.1002/cbf.3638. Epub 2021 May 24. PMID: 34028068.
7: Zhao Y, Liu P, Zhang Y, Jiang H, Luan H, Xu Y, Zhang Y, Li R.
Demethyleneberberine blocked the maturation of IL-1β in inflammation by
inhibiting TLR4-mitochondria signaling. Int Immunopharmacol. 2022 Dec;113(Pt
A):109319. doi: 10.1016/j.intimp.2022.109319. Epub 2022 Oct 17. PMID: 36252484.
8: Tao C, Hu SQ, Chen J, Chen YJ, Sun KH, Cui GZ, Ma M, Wu ZZ. Highly efficient
synthesis and monoamine oxidase B inhibitory profile of demethyleneberberine,
columbamine and palmatine. Neurochem Int. 2020 Oct;139:104807. doi:
10.1016/j.neuint.2020.104807. Epub 2020 Jul 22. PMID: 32711021.
9: Qiang X, Xu L, Zhang M, Zhang P, Wang Y, Wang Y, Zhao Z, Chen H, Liu X, Zhang
Y. Demethyleneberberine attenuates non-alcoholic fatty liver disease with
activation of AMPK and inhibition of oxidative stress. Biochem Biophys Res
Commun. 2016 Apr 15;472(4):603-9. doi: 10.1016/j.bbrc.2016.03.019. Epub 2016 Mar
9. PMID: 26970305.
10: Wang Y, Zhao Z, Yan Y, Qiang X, Zhou C, Li R, Chen H, Zhang Y.
Demethyleneberberine Protects against Hepatic Fibrosis in Mice by Modulating NF-
κB Signaling. Int J Mol Sci. 2016 Jun 30;17(7):1036. doi: 10.3390/ijms17071036.
PMID: 27376272; PMCID: PMC4964412.
11: Zhang M, Li Q, Zhou C, Zhao Y, Li R, Zhang Y. Demethyleneberberine
attenuates concanavalin A-induced autoimmune hepatitis in mice through
inhibition of NF-κB and MAPK signaling. Int Immunopharmacol. 2020 Mar;80:106137.
doi: 10.1016/j.intimp.2019.106137. Epub 2020 Jan 10. PMID: 31931366.
12: Liu J, Huang X, Liu D, Ji K, Tao C, Zhang R, Chen J. Demethyleneberberine
induces cell cycle arrest and cellular senescence of NSCLC cells via
c-Myc/HIF-1α pathway. Phytomedicine. 2021 Oct;91:153678. doi:
10.1016/j.phymed.2021.153678. Epub 2021 Jul 18. PMID: 34385092.
13: Zhang P, Qiang X, Zhang M, Ma D, Zhao Z, Zhou C, Liu X, Li R, Chen H, Zhang
Y. Demethyleneberberine, a natural mitochondria-targeted antioxidant, inhibits
mitochondrial dysfunction, oxidative stress, and steatosis in alcoholic liver
disease mouse model. J Pharmacol Exp Ther. 2015 Jan;352(1):139-47. doi:
10.1124/jpet.114.219832. Epub 2014 Oct 31. PMID: 25362106.
14: Han Y, Ge C, Ye J, Li R, Zhang Y. Demethyleneberberine alleviates
Pseudomonas aeruginosa-induced acute pneumonia by inhibiting the AIM2
inflammasome and oxidative stress. Pulm Pharmacol Ther. 2023 Dec;83:102259. doi:
10.1016/j.pupt.2023.102259. Epub 2023 Sep 17. PMID: 37726074.
15: Chen YY, Li RY, Shi MJ, Zhao YX, Yan Y, Xu XX, Zhang M, Zhao XT, Zhang YB.
Demethyleneberberine alleviates inflammatory bowel disease in mice through
regulating NF-κB signaling and T-helper cell homeostasis. Inflamm Res. 2017
Feb;66(2):187-196. doi: 10.1007/s00011-016-1005-3. Epub 2016 Nov 29. PMID:
27900412.
16: Ge C, Huang M, Han Y, Shou C, Li D, Zhang Y. Demethyleneberberine Alleviates
Pulmonary Fibrosis through Disruption of USP11 Deubiquitinating GREM1.
Pharmaceuticals (Basel). 2024 Feb 22;17(3):279. doi: 10.3390/ph17030279. PMID:
38543064; PMCID: PMC10974697.